Lorraine Blaise

717 total citations
28 papers, 232 citations indexed

About

Lorraine Blaise is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Lorraine Blaise has authored 28 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 15 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Lorraine Blaise's work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Liver Disease Diagnosis and Treatment (15 papers) and Liver Disease and Transplantation (6 papers). Lorraine Blaise is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Liver Disease Diagnosis and Treatment (15 papers) and Liver Disease and Transplantation (6 papers). Lorraine Blaise collaborates with scholars based in France, Italy and Democratic Republic of the Congo. Lorraine Blaise's co-authors include Nathalie Ganne‐Carrié, Jean‐Charles Nault, Olivier Séror, Manon Allaire, Olivier Sutter, Mathilde Wagner, François Cauchy, Valérie Paradis, Miguel Albuquerque and Olivier Soubrane and has published in prestigious journals such as Hepatology, Scientific Reports and Journal of Hepatology.

In The Last Decade

Lorraine Blaise

26 papers receiving 230 citations

Peers

Lorraine Blaise

HEPAT

EPIDE

ONCOL

SURGE

PRM

Burcin Özdirik Germany

Yichuan Yuan China

Francesca Garuti Italy

Satoshi Moriya Japan

Yichuan Yuan China

Ting‐Jung Wu Taiwan

Michinori Hamaoka Japan

Xuqi Sun China

Nutcha Pinjaroen Thailand

Mariella Di Marco Italy

Burcin Özdirik Germany

Lorraine Blaise

105 ×0.7

HEPAT

154 ×1.6

EPIDE

112 ×1.4

ONCOL

69 ×1.6

SURGE

55 ×1.6

PRM

Citations per year, relative to Lorraine Blaise Lorraine Blaise (= 1×) peers Burcin Özdirik

Countries citing papers authored by Lorraine Blaise

Since Specialization

Citations

This map shows the geographic impact of Lorraine Blaise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorraine Blaise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorraine Blaise more than expected).

Fields of papers citing papers by Lorraine Blaise

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorraine Blaise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorraine Blaise. The network helps show where Lorraine Blaise may publish in the future.

Co-authorship network of co-authors of Lorraine Blaise

This figure shows the co-authorship network connecting the top 25 collaborators of Lorraine Blaise. A scholar is included among the top collaborators of Lorraine Blaise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorraine Blaise. Lorraine Blaise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blaise, Lorraine, Marianne Ziol, Claudia Campani, et al.. (2025). Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma. JHEP Reports. 7(9). 101430–101430. 1 indexed citations

Pescatori, Lorenzo, G. Nkontchou, Abou Diallo, et al.. (2025). The role of early MRI in assessing the risk of local tumor progression following irreversible electroporation for hepatocellular carcinoma treatment. International Journal of Hyperthermia. 42(1). 2505595–2505595.

Campani, Claudia, D C Pallas, Όλγα Γιουλεμέ, et al.. (2024). Heterogeneity in adverse events related to atezolizumab-bevacizumab for hepatocellular carcinoma reported in real-world studies. JHEP Reports. 6(11). 101190–101190. 2 indexed citations

Sultanik, Philippe, Claudia Campani, Charles Roux, et al.. (2024). Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab. Digestive and Liver Disease. 56(9). 1621–1630. 7 indexed citations

Nault, Jean‐Charles, Richard Layese, Lorraine Blaise, et al.. (2024). Prolonged survival in women with hepatocellular carcinoma: A French observational study. Clinics and Research in Hepatology and Gastroenterology. 48(10). 102498–102498. 1 indexed citations

Sutter, Olivier, François Cauchy, Nathalie Ganne‐Carrié, et al.. (2024). Upfront multi‐bipolar radiofrequency ablation for HCC in transplant‐eligible cirrhotic patients with salvage transplantation in case of recurrence. Liver International. 44(6). 1464–1473. 1 indexed citations

Campani, Claudia, Marie Lequoy, Philippe Sultanik, et al.. (2024). No correlation between MASLD and poor outcome of Atezolizumab‐Bevacizumab therapy in patients with advanced HCC. Liver International. 44(4). 931–943. 5 indexed citations

Campani, Claudia, Manon Allaire, Philippe Sultanik, et al.. (2023). Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab. Hepatology. 79(1). 49–60. 14 indexed citations

Couty, Jean‐Pierre, Philippe Sultanik, Claudia Campani, et al.. (2023). Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC. Clinics and Research in Hepatology and Gastroenterology. 47(8). 102199–102199. 1 indexed citations

10.

Duvoux, Christophe, Lorraine Blaise, Monika Hurtova, et al.. (2023). The liver in sickle cell disease. La Presse Médicale. 52(4). 104212–104212. 1 indexed citations

11.

Müller, Marie, Lorraine Blaise, René Gerolami, et al.. (2023). Atezolizumab plus bevacizumab in advanced hepatocellular carcinoma after treatment failure with multikinase inhibitors. Digestive and Liver Disease. 55(7). 938–944. 2 indexed citations

12.

Campani, Claudia, Manon Allaire, Philippe Sultanik, et al.. (2023). Impact of radiological response and pattern of progression on overall survival in patients with hepatocellular carcinoma treated by atezolizumab-bevacizumab. Journal of Hepatology. 78. S585–S586. 2 indexed citations

13.

Sultanik, Philippe, Lorraine Blaise, Mathilde Wagner, et al.. (2022). A history of variceal bleeding is associated with further bleeding under atezolizumab–bevacizumab in patients with HCC. Liver International. 42(12). 2843–2854. 19 indexed citations

14.

Sutton, Angéla, Lorraine Blaise, Olivier Séror, et al.. (2022). Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 9. 1369–1383. 2 indexed citations

15.

Campani, Claudia, Lorraine Blaise, Nathalie Ganne‐Carrié, et al.. (2022). Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab–bevacizumab. Liver International. 43(3). 708–717. 27 indexed citations

16.

Gigante, Elia, Jean‐Charles Nault, Olivier Sutter, et al.. (2022). Imaging and histological features of tumor biopsy sample predict aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation. Scientific Reports. 12(1). 18712–18712. 2 indexed citations

17.

Roth, Gaël S., Stefano Caruso, Christian Sengel, et al.. (2022). Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization. World Journal of Gastroenterology. 28(36). 5324–5337. 11 indexed citations

18.

Blaise, Lorraine, Héléna Pereira, Valérie Vilgrain, et al.. (2021). Percutaneous ablation for locally advanced hepatocellular carcinoma with tumor portal invasion. Clinics and Research in Hepatology and Gastroenterology. 45(6). 101731–101731. 1 indexed citations

19.

Allaire, Manon, Ségolène Brichler, Lorraine Blaise, et al.. (2020). Prior surveillance and antiviral treatment improve the prognosis of HCC developed in HBV patients in the West. Clinics and Research in Hepatology and Gastroenterology. 45(1). 101436–101436. 4 indexed citations

20.

Guedj, Nathalie, Lorraine Blaise, François Cauchy, et al.. (2020). Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma. Modern Pathology. 34(2). 408–416. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact